Patents by Inventor Richard T. Robinson
Richard T. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240174040Abstract: A lift axle suspension system incorporating a lift paddle is disclosed. The lift paddle comprising a first pad, a second pad and a rigid support arm securing the first pad and the second pad in fixed relation to one another. The first pad is attached to a lift spring, the second pad is secured to the bottom surface of the main support member/leaf spring. Actuation of the lift spring causes the axle to be lifted out of contact with the ground surface.Type: ApplicationFiled: March 18, 2022Publication date: May 30, 2024Inventors: Ashley T. Dudding, Sean T. Lindsay, Ryan M. Ettenhofer, Michael P. Robinson, Richard J. Aumann
-
Patent number: 11992399Abstract: There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.Type: GrantFiled: May 24, 2022Date of Patent: May 28, 2024Assignee: Edwards Lifesciences AGInventors: Judith T. Carpenter, Jeffrey P. Carpenter, David A. Rezac, Jeffrey C. Cerier, Richard C. Fortier, Timothy W. Robinson
-
Patent number: 11957894Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.Type: GrantFiled: August 25, 2020Date of Patent: April 16, 2024Assignee: Medtronic, Inc.Inventors: Anthony M. Chasensky, Bernard Q. Li, Brad C. Tischendorf, Chris J. Paidosh, Christian S. Nielsen, Craig L. Schmidt, David A. Dinsmoor, Duane L. Bourget, Eric H. Bonde, Erik R. Scott, Forrest C M Pape, Gabriela C. Molnar, Gordon O. Munns, Joel A. Anderson, John E. Kast, Joseph J. Viavattine, Markus W. Reiterer, Michael J. Ebert, Phillip C. Falkner, Prabhakar A. Tamirisa, Randy S. Roles, Reginald D. Robinson, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Thomas P. Miltich, Timothy J. Denison, Todd V. Smith, Xuan K. Wei
-
Patent number: 11957893Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.Type: GrantFiled: August 25, 2020Date of Patent: April 16, 2024Assignee: Medtronic, Inc.Inventors: Brad C. Tischendorf, John E. Kast, Thomas P. Miltich, Gordon O. Munns, Randy S. Roles, Craig L. Schmidt, Joseph J. Viavattine, Christian S. Nielsen, Prabhakar A. Tamirisa, Anthony M. Chasensky, Markus W. Reiterer, Chris J. Paidosh, Reginald D. Robinson, Bernard Q. Li, Erik R. Scott, Phillip C. Falkner, Xuan K. Wei, Eric H. Bonde, David A. Dinsmoor, Duane L. Bourget, Forrest C M Pape, Gabriela C. Molnar, Joel A. Anderson, Michael J. Ebert, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Timothy J. Denison, Todd V. Smith
-
Patent number: 8877212Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a method of identifying an active M. tuberculosis infection. In another embodiment, the present invention contemplates a method of monitoring a M. tuberculosis infection. In yet another embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection. In a further embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection.Type: GrantFiled: February 11, 2013Date of Patent: November 4, 2014Assignee: Trudeau InstituteInventors: Richard T. Robinson, Andrea M. Cooper
-
Publication number: 20140227324Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a method of identifying an active M. tuberculosis infection. In another embodiment, the present invention contemplates a method of monitoring a M. tuberculosis infection. In yet another embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection. In a further embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection.Type: ApplicationFiled: February 11, 2013Publication date: August 14, 2014Inventors: Richard T. Robinson, Andrea M. Cooper
-
Patent number: 8394593Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a vaccine formulation comprising an antigen and IL12R?1 isoform 2. In some embodiments, this invention relates to a method of quantifying the ratio of IL12R?1 transcript and a splice variant thereof in a sample, including but not limited to at the cDNA level. In other embodiments, this invention relates to a method of augmenting an immune response by administering, inhibiting and/or inducing IL12R?1 isoform 2.Type: GrantFiled: February 7, 2011Date of Patent: March 12, 2013Assignee: Trudeau InstituteInventors: Richard T. Robinson, Andrea M. Cooper
-
Publication number: 20110256158Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a vaccine formulation comprising an antigen and IL12R?1 isoform 2. In some embodiments, this invention relates to a method of quantifying the ratio of IL12R?1 transcript and a splice variant thereof in a sample, including but not limited to at the cDNA level. In other embodiments, this invention relates to a method of augmenting an immune response by administering, inhibiting and/or inducing IL12R?1 isoform 2.Type: ApplicationFiled: February 7, 2011Publication date: October 20, 2011Applicant: Trudeau InstituteInventors: Richard T. Robinson, Andrea M. Cooper
-
Patent number: 6097866Abstract: An optical fiber ribbon is disclosed. The optical fiber ribbon comprises a plurality of optical fibers arranged in a parallel planar array, the planar array being further defined by first and second planar sides spanning between first and second ends. A matrix material coating envelops the optical fibers so as to bond the optical fibers together in the parallel planar array. The matrix material coating forms a first substantially planar surface section spanning the first planar side of the planar array of optical fibers. A second substantially planar surface section spans the second planar side of the planar array of optical fibers. A first hinge section bridges the first and second substantially planar surface sections at the first end of the planar array and a second hinge section bridges the first and second substantially planar surface sections at the second end of the planar array.Type: GrantFiled: May 1, 1998Date of Patent: August 1, 2000Assignee: AlcatelInventors: Houching M. Yang, Alfred L. Hinson, Richard T. Robinson
-
Patent number: 6066275Abstract: A method and apparatus for determining and controlling the excess length of a communications element disposed in a conduit is disclosed. The method includes the steps of measuring the length of a communications element being disposed within the conduit, placing a mark on the conduit each time a pre-determined length of the communications element is disposed within the conduit, and measuring the distance between the marks on the conduit. The excess length is determined by comparing the distance between the initial mark and the subsequent mark on the conduit to the measured length of the communications element disposed within the conduit. To control the excess length ratio, the conduit may be stretched, or process parameters related to formation of the conduit may be changed.Type: GrantFiled: July 7, 1998Date of Patent: May 23, 2000Assignee: AlcatelInventors: Richard T. Robinson, James J. Puzan
-
Patent number: 4511278Abstract: A connector unit for connecting the struts of a geodesic dome framework is disclosed. The connector unit has the general shape of a frustum of a right circular cone. Five equally spaced rectangular depressions are formed in the upper surface of the frustum and a pair of flanges in mirror image relationship in planes perpendicular to the planes of the rectangular depressions are placed on opposite sides of each rectangular depression and each flange of the pair has an opening in its central area with the openings in register with each other.Type: GrantFiled: March 2, 1983Date of Patent: April 16, 1985Assignee: Delta Engineering Co.Inventor: Richard T. Robinson
-
Patent number: D259553Type: GrantFiled: June 22, 1978Date of Patent: June 16, 1981Assignee: August G. CarloniInventor: Richard T. Robinson